Max-E47 hybrid peptide analogs (MSD)

N/A

Report date: 2025/03/20 14:46:15

Base Information

Drug NameMax-E47 hybrid peptide analogs (MSD)
Drug Alias NameME-47 analogs (MSD)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionMyc proto-oncogene protein inhibitors
TargetsMyc proto-oncogene protein
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMsd Kk
China Registration ClassN/A

Develop Information

Active CompaniesMsd Kk
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A